Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Radiology and Oncology
Volume 56 (2022): Numero 2 (June 2022)
Accesso libero
Cervix-Online computer program: 27 years of hospital-based clinical registry for cervical cancer at the University Medical Centre Maribor
Vida Gavric Lovrec
Vida Gavric Lovrec
,
Darja Arko
Darja Arko
e
Iztok Takac
Iztok Takac
| 22 dic 2021
Radiology and Oncology
Volume 56 (2022): Numero 2 (June 2022)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Articolo
Immagini e tabelle
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Article Category:
Research Article
Pubblicato online:
22 dic 2021
Pagine:
198 - 207
Ricevuto:
13 set 2021
Accettato:
22 nov 2021
DOI:
https://doi.org/10.2478/raon-2021-0054
© 2022 Vida Gavric Lovrec, Darja Arko, Iztok Takac, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1
General data. CT = chemotherapy; RT = radiotherapy
Figure 2
Medical history, clinical examination, clinical stage (preoperative International Federation of Gynecology and Obstetrics [FIGO] stage). AGC - neoplastic = atypical glandular cells - neoplastic; AGC-NOS = atypical glandular cells - not otherwise specified; AIS = adenocarcinoma in situ; AC = adenocarcinoma; ASC-US = atypical squamous cells - of undetermined significance; ASC-H = atypical squamous cells - cannot exclude HSIL; GIT = gastrointestinal tract; HGSIL = high grade squamous intraepithelial lesion; IUD = intrauterine device; IUS = intrauterine system; LGSIL = low grade squamous intraepithelial lesion; MLG-N = other malignant cells - inevaluable; MTOP = medical termination of pregnancy; N/A = not available; SCC = squamous cell carcinoma; SFM-NOS = suspicious for malignancy - not otherwise specified
Figure 3
Tests at initial examination. CEA = carcinoembryonic antigen; L = left; NAD = no evidence of disease; R = right; SCC = squamous cell carcinoma antigen
Figure 4
Treatment. CT = chemotherapy: DVT = deep vein thrombosis; G-CSF = granulocyte colony stimulating factor
Figure 5
Histopathology, International Federation of Gynecology and Obstetrics (FIGO) stage after definitive histology. L = left; R = right
Figure 6
Chemotherapy cycles. CEA = carcinoembryonic antigen; G-CSF = granulocyte colony stimulating factor; NAD = nothing abnormal detected; SCC = squamous cell carcinoma antigen
Figure 7
Follow-up form. TH = therapy; NAD = nothing abnormal detected; ASC-US = atypical squamous cells of undetermined significance; ASC-H = atypical squamous cells – cannot exclude HSIL; LGSIL = low-grade squamous intraepithelial lesion ; HGSIL = high grade squamous intraepithelial lesion; SCC = squamous cell carcinoma; AGC-NOS = atypical glandular cells not otherwise specified; AGC-neoplastic = atypical glandular cells, suspicious for AIS or cancer; AIS = adenocarcinoma in situ; AC = adenocarcinoma; SFM-NOS = suspicious for malignancy; MLG-N = malignancy; SCC = squamous cell carcinoma antigen; CEA = carcinoembryonic antigen; UTI = urinary tract infection
Anteprima